Ninerafaxstat

N/A

Report date: 2026/04/28 20:00:22
NME

Base Information

Drug NameNinerafaxstat
Drug Alias NameIMB-1018972 trihydrochloride monohydrateIMB-101IMB-1018972IMB-1018792CV-8972
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPartial fatty acid oxidation inhibitors
TargetsUpdating
Therapy Area/IndicationsIschemiaDiabetes Mellitus, Type 2Coronary Artery Disease +[7
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesSweden +[14
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesImbria Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsIschemiaDiabetes Mellitus, Type 2Coronary Artery Disease +[6
Inactive IndicationsAngina Pectoris

Other Information

ATC CodeN/A
Related LinksWikipedia